- Pre-clinical testing.
- Phase I clinical trials.
- Pharmacovigilance.
- Drug development.
8. A new drug for Type 2 Diabetes is reported to cause a rare, severe liver injury in post-marketing surveillance. What medicinal epidemiological activity is this indicative of?
Facebook
WhatsApp
